Role of Biomarkers for the Management of Ulcerative Colitis
Positioning of new S1P receptor modulators to optimize patient outcomes in UC
Optimizing advanced therapy for moderate to severe ulcerative colitis
Emerging evidence for S1P receptor modulators in ulcerative colitis
Managing a patient with advanced isolated proctitis, a subtype of ulcerative colitis